0.00Open3.90Pre Close0 Volume1 Open Interest67.00Strike Price0.00Turnover82.77%IV-12.39%PremiumDec 6, 2024Expiry Date13.93Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9945Delta0.0026Gamma5.74Leverage Ratio-0.0175Theta0.0055Rho5.71Eff Leverage0.0012Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet